Just two days after the FDA announced it was considering a Tavneos drug recall, Amgen countered with a Tavneos label change that adds warnings for vanishing bile duct syndrome (VBDS). As regards this April 2026 Tavneos label change adding more liver side effects, and specifically the new warning … More
Main Navigation Menu
➤ Current Drug Injury Lawsuits / Pharmaceutical Litigations
➤ Drug Injury Case Evaluation – Free. Confidential. No Obligation.
➤ Information About the Law Offices of Thomas J. Lamb
➤ Questions New Clients Have Asked Us (FAQs)
➤ Patient Resources: Medical Sites and More
➤ Recent Side Effects Blog Articles
➤ Collection of Earlier Blog Articles
To save time, you can use our Quick Contact Form to tell us about your possible case.
Recent News & Case Reports
Tavneos Legal Cases: Drug Injury Law Information – Five (5) Points
We are investigating Tavneos legal cases for people who have developed the Tavneos side-effects of vanishing bile duct syndrome (VBDS) or drug-induced liver injury (DILI). In this post, we share some case criteria and drug injury law information, presenting factors relevant to a possible "new" … More
Tavneos FDA Warnings: Liver Side Effects, Death Cases
In March 2026, Tavneos FDA warnings about liver side effects and some death cases were issued, just a couple of months after the FDA had requested that Amgen recall Tavneos for drug safety reasons. According to the FDA, Tavneos (avacopan) is used together with glucocorticoids and other … More
Ozempic and Wegovy NAION Study 2026 Report: Two New Findings
A recent Ozempic and Wegovy NAION study made two new findings about people who used Ozempic or Wegovy and then were diagnosed with non-arteritic anterior ischemic optic neuropathy (NAION) as a drug side effect that caused vision loss. The first is that the Wegovy NAION rate is five times that of … More
Ozempic-NAION Warnings Should Be In January 2026 Drug Label For New Pill Version
We have written about the Ozempic-NAION side effect drug safety issue several times over the past year-and-a-half, and have repeatedly pointed out that NAION is linked to semaglutide, the active ingredient in the currently available Novo Nordisk semaglutide medicines: Ozempic injection, Wegovy … More
Ozempic NAION Risk 200% Higher Than Some Other Diabetes Drugs
The semaglutide-containing drug Ozempic has been linked to non-arteritic anterior ischemic optic neuropathy (NAION). A 2026 medical journal article reported that the Ozempic NAION risk 200% higher than that of some other diabetes drugs, such as Invokana (canagliflozin), Jardiance (empagliflozin), … More